Hemostemix Inc. is experiencing a notable surge in its stock price, drawing attention from investors.
Hemostemix Inc. (HEM.V) is rising today, with shares up by 7.69%, closing at CA$0.07. This upward movement is noteworthy for a company with a market cap of just over CA$13 million. Investors are keenly observing this small-cap stock as it gains momentum in the market.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$13.32M
52W high
$0.14
52W low
$0.04
1W change
+8.33%
Beta
0.61
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
136.6%
Annualized
90-Day Vol
115.2%
Annualized
Trend (90d)
+33.6%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.04 – C$0.11 |
| 60 trading days | C$0.07 | C$0.04 – C$0.14 |
| 90 trading days | C$0.07 | C$0.03 – C$0.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent price increase may signal growing investor interest, but caution is advised given the company's limited news flow and market cap.
Stock Gains 7.69% in One Day
Hemostemix Inc. has seen its stock price rise significantly, reflecting a potential shift in market sentiment towards the company.
Bull case
The rise in Hemostemix's stock might show a growing interest in biotech companies, especially those working on innovative therapies. If the company announces any new developments or partnerships, it could boost investor confidence even more.
Bear case
Even with the positive movement, Hemostemix Inc. is in a volatile sector and hasn't released much news lately. Investors should be cautious about the risks tied to small-cap stocks, particularly in biotech, where performance can be unpredictable.
Market Response
Advertisement
The market's reaction to Hemostemix Inc.'s stock surge reflects investor sentiment towards small-cap biotech firms. With the stock price climbing, many investors are taking a closer look at the company's fundamentals and potential future developments.
Potential Drivers
While there hasn't been significant news recently, the rise in stock price may be due to speculative trading or renewed interest in the biotech sector. Investors should keep an eye out for any upcoming announcements or developments that could impact Hemostemix's trajectory.
Looking Ahead
As Hemostemix Inc. continues to rise today, investors should remain vigilant. The company's market cap and lack of recent news could mean volatility ahead, making it crucial for investors to stay informed about any changes in the company's status or the broader market conditions.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
